Top Page
CLSA Premium Ltd.
(6877)
CLSA Premium Ltd. (6877) vs. S&P 500 (SPY)
CLSA Premium Ltd. Business Overview & Revenue Model
CLSA Premium Ltd. Financial Statement Overview
| Breakdown | ||||
| Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|
| Income Statement | Total Revenue | |||
| 86.49M | 199.68M | 40.39M | 2.78M | 4.71M | Gross Profit |
| 28.26M | 43.06M | -5.30M | -23.04M | -15.95M | EBIT |
| -2.85M | 14.57M | -29.21M | -57.62M | -80.56M | EBITDA |
| -2.54M | 15.03M | -9.29M | -36.79M | -67.28M | Net Income Common Stockholders |
| 11.34M | 9.84M | -29.52M | -56.54M | -71.64M |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
| 205.17M | 222.39M | 211.79M | 234.47M | 289.83M | Total Assets |
| 279.38M | 251.78M | 284.31M | 330.62M | 430.44M | Total Debt |
| 0.00 | 1.28M | 6.86M | 9.64M | 10.70M | Net Debt |
| -205.17M | -222.39M | -204.93M | -224.83M | -276.08M | Total Liabilities |
| 35.08M | 11.91M | 53.51M | 61.86M | 97.38M | Stockholders Equity |
| 244.31M | 239.87M | 230.80M | 268.76M | 333.06M |
| Cash Flow | Free Cash Flow | |||
| -19.90M | 1.82M | -16.79M | -40.12M | -6.50M | Operating Cash Flow |
| -19.90M | 1.82M | -16.79M | -39.26M | -5.87M | Investing Cash Flow |
| 9.48M | 9.64M | 1.78M | 2.21M | -2.58M | Financing Cash Flow |
| 0.00 | -1.00K | -2.12M | -10.14M | -12.35M |
CLSA Premium Ltd. Technical Analysis
CLSA Premium Ltd. Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
64 Neutral | $12.60B | 9.73 | 7.92% | 16985.68% | 12.21% | -5.55% | |
57 Neutral | HK$853.98M | 75.00 | 4.68% | ― | -48.61% | 16.67% | |
53 Neutral | HK$2.56B | ― | -5.91% | 0.62% | 0.93% | 17.34% | |
47 Neutral | €135.60M | ― | -9.22% | ― | -5.75% | 57.80% | |
43 Neutral | €38.59M | ― | -6.76% | ― | -29.37% | 75.02% | |
39 Underperform | HK$166.82M | ― | -82.56% | ― | 79.84% | -219.70% |
CLSA Premium Ltd. Corporate Events
CLSA Premium Limited announced a change in its head office and principal place of business in Hong Kong, effective from May 1, 2025. The relocation to Central Plaza, Wanchai, Hong Kong, along with updates to its contact information, signifies a strategic move that may impact its operational efficiency and stakeholder engagement.
CLSA Premium Limited has announced its upcoming annual general meeting scheduled for May 9, 2025, in Hong Kong. Key agenda items include the adoption of financial statements for the year ending December 31, 2024, the re-election of several directors, and the re-appointment of BDO Limited as auditors. Additionally, the company seeks approval for a general mandate to issue additional shares, which could impact its market positioning and shareholder value.
CLSA Premium Limited announced significant changes in its board of directors, effective April 2025, with the resignation of three directors due to personal and professional reasons. The company expressed gratitude for their contributions and simultaneously appointed new directors, including Mr. Ji Guangfei as the Chairman and CEO, and Ms. Li Jiang as the Deputy Chairman, to lead the company with their extensive experience in corporate management and healthcare.
CLSA Premium Limited announced a clarification regarding the closure of its register of members for a specified period in May 2025. This closure is necessary for shareholders to qualify for attending and voting at the upcoming Annual General Meeting (AGM), ensuring proper registration of share transfers by the specified deadline.
CLSA Premium Ltd. has announced the closure of an unconditional mandatory cash offer made by Shanggu Securities Limited on behalf of Beijing Tong Ren Tang (Cayman) Limited. The offer, which closed on April 1, 2025, resulted in Beijing Tong Ren Tang acquiring approximately 79.01% of CLSA Premium’s total issued share capital. This acquisition marks a significant shift in the company’s ownership structure, potentially impacting its strategic direction and market positioning.
CLSA Premium Limited has announced its audited results for the year ending December 31, 2024, revealing a significant decrease in sales from its healthcare business, dropping from HK$191,170,000 in 2023 to HK$86,489,000 in 2024. Despite this decline, the company managed to maintain a profit from continuing operations at HK$11,338,000, slightly down from the previous year’s HK$12,830,000, indicating resilience amidst challenging market conditions. The company also proposed a change of its name and amendments to its Memorandum and Articles of Association, signaling potential strategic shifts to better align with its evolving business focus.
CLSA Premium Limited, a company listed on the Hong Kong Stock Exchange, has announced that there is no change in the advice provided by its Independent Financial Adviser, Somerley Capital Limited, regarding an unconditional mandatory cash offer made by Shanggu Securities Limited on behalf of Beijing Tong Ren Tang (Cayman) Limited. The advice remains that the offer is fair and reasonable, and shareholders are encouraged to carefully review the relevant documents before making a decision. The announcement underscores the importance of caution for shareholders and potential investors in dealing with the company’s shares.
CLSA Premium Limited, a company incorporated in the Cayman Islands, is the subject of an unconditional mandatory cash offer by Shanggu Securities Limited on behalf of Beijing Tong Ren Tang (Cayman) Limited. The offer, which excludes shares already owned by Beijing Tong Ren Tang or its affiliates, involves the despatch of a composite document detailing the offer’s terms, timetable, and recommendations to independent shareholders. The offer period began on March 11, 2025, and will close on April 1, 2025, with results announced the same day. This move could potentially impact the company’s market positioning and shareholder value.
CLSA Premium Limited, a company incorporated in the Cayman Islands, has announced that its board of directors will convene on March 17, 2025. The meeting’s agenda includes approving the annual results for the year ending December 31, 2024, and considering a final dividend recommendation. This announcement indicates a significant step in the company’s financial reporting process, potentially impacting its stakeholders and market performance.
CLSA Premium Limited, a company incorporated in the Cayman Islands, announced the appointment of Somerley Capital Limited as an independent financial adviser. This move is part of the company’s compliance with the Takeovers Code, as it evaluates an offer involving its shareholders. The appointment seeks to provide independent advice on the fairness and reasonableness of the offer, enhancing transparency and ensuring informed decision-making for stakeholders.
CLSA Premium Limited, incorporated in the Cayman Islands, has entered a Share Transfer Agreement with Beijing Tong Ren Tang (Cayman) Limited. The agreement involves the transfer of 813,316,000 shares, representing 40% of CLSA’s total issued share capital, for HK$97,994,000. This transaction obliges the Offeror to make an unconditional mandatory cash offer for all remaining shares of CLSA Premium Limited not already owned or agreed to be acquired by the Offeror. This strategic move increases the Offeror’s stake to 59.03% of the company, indicating a significant shift in control and a potential impact on the company’s market operations and investor landscape.